Burke MD - Search Results

1

Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line.

Grant MH, Duthie SJ, Gray AG, Burke MD. Grant MH, et al. Among authors: burke md. Biochem Pharmacol. 1988 Nov 1;37(21):4111-6. doi: 10.1016/0006-2952(88)90103-7. Biochem Pharmacol. 1988. PMID: 2847753

2

Fluorescence-microscopic measurement of intracellular cytochrome P-450 enzyme activity (ethoxyresorufin O-de-ethylation) in unfixed liver section.

Burke MD, Murray GI, Lees GM. Burke MD, et al. Biochem J. 1983 Apr 15;212(1):15-24. doi: 10.1042/bj2120015. Biochem J. 1983. PMID: 6870848 Free PMC article.

3

Monoclonal antibodies against human cytochrome P-450 recognizing different pregnenolone 16 alpha-carbonitrile-inducible rat cytochromes P-450.

Barnes TS, Shaw PM, Burke MD, Melvin WT. Barnes TS, et al. Among authors: burke md. Biochem J. 1987 Nov 15;248(1):301-4. doi: 10.1042/bj2480301. Biochem J. 1987. PMID: 3435446 Free PMC article.

4

Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.

Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT. Burke MD, et al. Biochem Pharmacol. 1994 Aug 30;48(5):923-36. doi: 10.1016/0006-2952(94)90363-8. Biochem Pharmacol. 1994. PMID: 8093105

5

Isolation and comparison of endoplasmic reticulum membranes and their mixed function oxidase activities from mammalian extrahepatic tissues.

Burke MD, Orrenius S. Burke MD, et al. Pharmacol Ther. 1979;7(3):549-99. doi: 10.1016/0163-7258(79)90042-1. Pharmacol Ther. 1979. PMID: 392562 Review. No abstract available.

6

The effects of dimethylsulphoxide and 5-aminolaevulinic acid on the activities of cytochrome P450-dependent mixed function oxidase and UDP-glucuronosyl transferase activities in human Hep G2 hepatoma cells.

Doostdar H, Burke MD, Melvin WT, Grant MH. Doostdar H, et al. Among authors: burke md. Biochem Pharmacol. 1991 Aug 22;42(6):1307-13. doi: 10.1016/0006-2952(91)90271-6. Biochem Pharmacol. 1991. PMID: 1653569 No abstract available.

7

Evidence for a new cytochrome P450 form induced by 3-methylcholanthrene in rats.

Weaver RJ, Dunbar B, Dickins M, Melvin WT, Fothergill J, Burke MD. Weaver RJ, et al. Among authors: burke md. Biochem Pharmacol. 1994 Apr 20;47(8):1457-60. doi: 10.1016/0006-2952(94)90348-4. Biochem Pharmacol. 1994. PMID: 8185654

8

A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes.

Weaver RJ, Thompson S, Smith G, Dickins M, Elcombe CR, Mayer RT, Burke MD. Weaver RJ, et al. Among authors: burke md. Biochem Pharmacol. 1994 Mar 2;47(5):763-73. doi: 10.1016/0006-2952(94)90475-8. Biochem Pharmacol. 1994. PMID: 8135852

9

Decreased hepatic microsomal cytochrome P450 due to indomethacin: protective roles of 16,16-dimethylprostaglandin F2 alpha and inducing agents.

Burke MD, Falzon M, Milton AS. Burke MD, et al. Biochem Pharmacol. 1983 Feb 1;32(3):389-97. doi: 10.1016/0006-2952(83)90516-6. Biochem Pharmacol. 1983. PMID: 6847694

10

Are the decreases in hepatic cytochrome P-450 and other drug-metabolising enzymes caused by indomethacin in vivo mediated by intestinal bacterial endotoxins? 16,16-Dimethylprostaglandin F2 alpha prevents decreases in hepatic drug-metabolising enzymes due to exogenous endotoxin.

Falzon M, Milton AS, Burke MD. Falzon M, et al. Among authors: burke md. Biochem Pharmacol. 1984 Apr 15;33(8):1285-92. doi: 10.1016/0006-2952(84)90182-5. Biochem Pharmacol. 1984. PMID: 6370266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results